SEOUL, South Korea — The first shipment of U.S. beef in nearly three years arrived in South Korea on Monday after the country lifted an import ban triggered by fears of mad cow disease, the Agriculture Ministry said.
The nine-ton shipment of American beef was processed at a Kansas slaughterhouse and arrived on a Monday morning flight, said Lee Sang-kil, a director-general at the ministry.
WOULD you want to know if you were carrying human mad cow disease? Maybe not, but what if you'd given blood and maybe passed vCJD on to other people. Should they be tested?
No routine test is available yet, but that hasn't stopped the UK Health Protection Agency thrashing out the ethical issues before one comes along. On 19 October it launched a public consultation to gauge how people feel about the prospect of testing.
MONTREAL, QUEBEC--(CCNMatthews - Oct. 25, 2006) - BSafE Innovations Inc. (BSafE), a joint venture company owned by ProMetic Life Sciences Inc. (TSX:PLI) and Top Meadow Farms, dedicated to veterinary applications of prion research, is delighted to announce preliminary findings from its most recent testing.
BSafE has in-licensed some veterinary applications of proprietary technologies developed by Pathogen Removal and Diagnostic Technologies Inc. ("PRDT"), a joint venture between the American Red Cross and ProMetic Life Sciences Inc. (ProMetic).
BSafE relies on the same PRDT platform technology and core competency used to develop the first human prion blood filter which just received European regulatory approval and which will be launched on a commercial scale by MacoPharma over the coming months.
Encouraged by the performance of the technology with human prions, PRDT scientists have been working on behalf of BSafE to demonstrate that the technology can be adapted to target specifically the bovine form of prions. Recent experiments have confirmed the ability of the proprietary technology to greatly enhance the sensitivity of post mortem testing for Mad Cow Disease.
TOKYO (Reuters) - Japan will inspect about 910 tons of U.S. beef that has been stored in Japanese warehouses for more than eight months because of worries about mad cow disease, and will allow it to be sold if it meets Japan's safety requirements
Inspections will begin on Friday and will take about a month, a Health Ministry official said on Wednesday.
The ministry will ask importers of the product to open all the boxes containing the beef to see if they include banned material or meat from old cattle, he said.
The farm and health ministries will also conduct inspections of the beef separately for any violations of safety requirements, he added.
A case of bovine spongiform encephalopathy (BSE) or mad cow disease has been discovered in the Russian enclave of Kaliningrad between Poland and Lithuania, the Federal Control Service for Consumer Rights said.
.
"A case of mad cow disease was detected in the town of Razdolnoye in the Nesterovski region," near the Lithuanian border, it said in a press release.
.
"The two people who had contact with the animal have received vaccinations," it added, saying that authorities are "taking measures designed to eliminate the source of the disease."
NSW health authorities are conducting tests to confirm if a hospital patient died as the result of a brain disease that may have infected other patients.
Doctors at John Hunter Hospital in Newcastle began to suspect on Tuesday that a middle-aged man who died on Wednesday had Creutzfeldt-Jakob Disease - the human form of mad cow disease.
The man was admitted to hospital 10 weeks ago, suffering neurological symptoms including severe headaches and involuntary muscle movements, and underwent several operations.
Hunter New England Health director of clinical operations, Nigel Lyons, said the likelihood that the patient had CJD was "very remote".
Continue reading after the jump
www.todayonline.com/articles/147812.asp
A nine-year-old cow in eastern France has tested positive for mad cow disease, the sixth case detected in the country this year, officials have said.The animal was tested after slaughter in September. It had been raised in Gresin, in the Savoie region.The number of French cases of bovine spongiform encephalopathy (BSE) has been declining steadily, from a peak of 274 in 2001 to 31 last year.France has recorded a total of 15 cases of the human form of the disease, variant Creutzfeldt-Jakob Disease, since it first appeared in 1996.There were more than 150 such human cases in Britain, which was at the epicentre of the mad cow phenomenon. — AFP
NEW YORK, Oct. 10, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) announced today that Prion Developmental Laboratories ("PDL"), its minority owned subsidiary company, entered into a contract manufacturing agreement with InBios International, Inc. ("InBios"), a leading biotechnology company in Seattle, Washington, to manufacture PDL's Mad Cow Disease ("BSE") and other TSE Rapid Diagnostic Tests.
Under the terms of the agreement InBios will manufacture PDL's BSE Rapid Diagnostic Tests to PDL's design specifications and quality control acceptance criteria. InBios will validate the manufactured BSE Rapid Assay tests meet or exceed PDL's performance criteria. Immediately following manufacture validation InBios will produce BSE Rapid Diagnostic Tests for PDL's customer evaluations, regulatory approvals, and customer sales.
"This is an important step in our commercialization of PDL's BSE Rapid Assay, and completes our search with PDL to identify a top manufacturing company to produce our quality product for us," said Douglas C. Lane, CEO and President of Genesis Bioventures. "InBios is an outstanding biotechnology company comprised of experienced scientists, professionals and executives. They were selected because of their experience and ability to manufacture the diagnostic test strips and because of their experience with the FDA and USDA in test approval. With this manufacturing agreement in place we are on track to initiate sales in 2007 under our worldwide exclusive distribution and sales license with PDL."
Enter keywords:
See our list of services or enter your information below to send us a quick message and we'll reply in one business day or less.
Your privacy is ensured. We will never sell, disclose, or trade contact information.
